Pacira BioSciences Inc. (NASDAQ:PCRX)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
PCRX Weekly Chart

Old Forum Content for PCRX

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • wineinquirer: $PCRX Marketsmith Somehow have missed the long range potential of Pacira ($PCRX) on IBD Tech Leaders. They have a few proprietary products/technology to reduce both post-op and osteoarthritic pain. More on their website. Zoom out to wkly where a multi-yr cup is dvlpg. Within this, noted a wkly c&h (2016-2021) with a handle pivot just surpassed on Fri. Even more interesting, the handle reveals a daily cup formation. While no handle on this yet, watch for one. Would be a very constructive short and long term pattern. 1rst tgt looks to be ~110, then 120-130. ATH bo could reach 200. Lastly, I cannot seem to load Marketsmith off the IBD site. If anyone else is experiencing the same, could you give me a heads up? Thx all..............
  • Henry: @wineinquirer $PCRX I had their local anesthetic Exparel. I didn't have any serious pain from a shoulder replacement for 4 days. That said, the charge for 4 teaspoons worth of local anesthetic was well North of $1,000
  • wineinquirer: $PCRX If you have health insurance (I pray you do), will it cover some portion of the local? Hope you're on the way or better yet, fully recovered.
  • debeers: @Henry $PCRX -i don't care about the drug--just you, H. Hope you get better quickly and know that we are all sending good thoughts your way.
  • issues: @bud_ozborn $IBB Cramer has been talking up medical stocks. He says since they do well even with rate hikes. $IBB, $XLV etc. I took a gander at biotechs and am buying these two in the morning: $AMPH (good BO with vol) $PCRX. We own $VRTX and put in limit orders for $AMGN and $GLPG. These are all from IBD industry group 99. I am buying $XLV in the morning. Great chart BO!!
  • steve71: @jpoko13 $HZNP $AMGN $ABBV $HZNP $MYOV $PCRX $REGN $VRTX The biotech fromula that has worked for a month is to pick companies with the following attributes: one or more FDA approved products, growing revenue, growing earnings, plenty of cash and a promising pipeline. The seven listed above mostly make the grade. It's better to pick stocks than to buy the $XBI. Buying small, cash burners with only spec drugs is the WRONG answer with rising interest rates.
  • traderbren: #Weeklies - just FYI to keep track of as weekly charts look more promising: $ETSY, $PYPL, $WST, $VIPS, $MED, $CDNS, $TREX, $DHI, $PCRX, $VICI, $RCII, $JD, $AMD, $GRVY, $LAD, $BBY, $RNG, $CHWY, $ABT, $ADSK -- as always, make sure you check when earnings are due.
  • issues: I like these three bio techs: $CLDX $FOLD $PCRX. The others in the IBD group include $APVO $DNLI but they are too extended. My first choice would be CLDX then FOLD and finally PCRX. Any ideas or holders?
  • issues: $BBIO looks real good. I also like these bios: $CLDX $FOLD & $PCRX but NP yet. Too extended $APVO $DNLI
  • issues: @AlexJFraser $BBIO I like this chart! It may be the right price. I can't decide between that one and one of these: $CLDX $FOLD $PCRX. NP yet
  • AlexJFraser: @issues $BBIO $CLDX $FOLD $PCRX I am most comfortable with the $bbio chart for my trading. I have been watching for a bit. Nice breakout, Earnings date isn't an issue now until next year. I got in yesterday and added a bit today. It looks like it has 16 days of short interest according to ShortSqueeze. Good luck!
  • vfr777: $PCRX Looks like it might be a good place to start a short term position. Earnings 8/6 BMO
  • DAN: Good morning. I was doing some thinking over the weekend about the challenges facing members of Stock Market Mentor (and Option Market Mentor too). Time frame. You have to take time frame into account in everything you do in trading. Your analysi ...
  • Bwhitty: $PCRX Thoughts on this one? It was said possibly buy on pull back nut now it has found support from 50 day.
  • Pcdentist: @DAN $FNV $SPX $DJI $DJT $NDX $FFTY $GLD $VIPS $NFLX $DXCM $TDOC $RNG $CCL $RCL $NCLH $PLMR $SGEN $SHOP $PCRX $LULU I have watched a thousand SMM video’s,,,That was THE BEST ONE ! Thanks! @Dan Simple is awesome
  • DAN: ...
    $PCRX -- I’d wait for a better entry on this. Very volatile...but improving fundamentals.
    $LULU -- breakout day. BuPS on OMM.

  • issues: On the IBD 50 list is $EBS - develops vaccines against biological agents that are potential weapons. New this week on IBD 50: $CI $CONE $CRUS $DPZ $DQ $ENVA $ICHR $FOCS $GDDY $GO $GSX $KBH $LAKE $MDC $NSIT $PCRX $POWI $QDEL $SIMO $TNK $XP $ZM Many seem related to the overblown Corona panic... Off the IBD 50: $AMN $AYX $BAH $BLK $BRBR $BRO $BSX $CHGG $COLD $CTRE $DXCM $ENV $FND $PFSI $RNG $RP $EPAY $SITE $STAG $TEAM $TTD $VAR Cramer said he expects another down draft this week sometime that will drop below the low on Thursday. I put in low limit orders (small number of shares) on $AMZN $GOOGL and $CABO
  • woodman: For what little it may be worth: GS #Biotech stocks where GS analysts see the highest M&A probability: $BLUE $BMRN $BPMC $CLVS $CRSP $INCY $MDGL $PCRX $PTLA $RVNC $SAGE $SRPT
  • shoredriver: @woodman $BLUE $BMRN $BPMC $CLVS $CRSP $INCY $MDGL $PCRX $PTLA $RVNC $SAGE $SRPT #Biotech .....$CLVS.....ugly memory.......
  • woodman: @shoredriver $BLUE $BMRN $BPMC $CLVS $CRSP $INCY $MDGL $PCRX $PTLA $RVNC $SAGE $SRPT #Biotech - BMRN has been on that list forever. Broken clock. Eventually they will be right about it getting bought.
  • gwenzee: @woodman $BLUE $BMRN $BPMC $CLVS $CRSP $INCY $MDGL $PCRX $PTLA $RVNC $SAGE $SRPT #Biotech I've been waiting for someone to scoop up INCY for quite awhile. At least it has come off of the recent lows. Someone is throwing me a lifeline which I really need on this one.
  • champ: @bnnybklyn @mopick #politics #Negotiating --- No but I did watch the Presidents, talk today on Fox News, with law-enforcement and family who loss love ones, big audience and it was only about drug addictions and ways to solve the problem. This happen today in NH, at 2:30 ET, because they have a huge problem their or had. These are Drug Related stocks...$INSY, $CAH $ABC $BDSI $DEPO $OPNT $$PCRX and these related prison stocks $CXW $GEO. He also talked about making it a crime for Doctors and Pharmacist, who don't follow the laws and some Doctors overprescribe the drugs. This has been talked about for years also...many are dying because of these drugs.
  • woodman: @gwenzee $JUNO $RXDX #Biotech $BLUE up ~7% in the afterhours. Biotech will jump tomorrow. Fwiw, GS sees these as having the highest M&A probability in biopharma (some of these are perennial buyout names): $AVXS $SAGE $SRPT $BMRN $BLUE $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $JUNO $SGEN $MNTA $BIVV.
  • gwenzee: @woodman $JUNO $RXDX $BLUE $AVXS $SAGE $SRPT $BMRN $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $SGEN $MNTA $BIVV #Biotech Thanks for the info. Previously held JUNO, BLUE, SRPT. Currently hold only INCY.
  • Henry: $PCRX reported results of a study of their long acting local anesthetic. One center violated the protocol in some fashion and the headline is the drug did not achieve the end point in lower extremity surgery. However if that center is excluded, the drug was statistically significant. The stock is down 9% on the headline. The people running these studies get paid a lot of money. It's a bonehead move to change the protocol on your own.
  • Bridget: $PCRX I don't know much about this company but I like this pattern. Breaking above the 200MA after a pennant. Seeing increased volume on this breakout. ER on 2/23. IV is also pretty high if you want to do a covered call. But also beware this is a biotech stock and comes with all the dangers that I have come to expect from them.
  • JJT1: $PCRX 4th day bumping up against 200 day SMA. No position.
  • traderbren: $PCRX -- np, but setting an alert for a move above $46.10
  • mradams0621: @GreenGhost $ARRY #gapers $ARRY Thanks for your thoughts. I'll try to pick your brain more about this after hrs., or weekend. Not trying to argue with Yoda / the master but just pointing out what I'm observing and looking for the wisdom of others. Tracking gapers list. Observations: Gapers that begin with good news plus opening gap trade with unusually high volume plus morning pull back can make good set ups for short term day bounce and swing trades. From yesterdays list, as examples, $FI, $LL, $PCRX, $VRX, $KTOV Will $ARRY follow the pattern? I'm keeping track. Usually have other duties during the open and can't do the 59min trades. But bounce trades mid-morning are looking more interesting. How to determine when to swing overnight vrs day trade would be nice to know. Some work, some not so much. Still gathering data.
  • mradams0621: ...
    13.09% $PCRX Pacira Pharmaceuti 70.60 48400
    11.68% $ICPT Intercept Pharmace 156.00 39860
    10.24% $ATRS Antares Pharma Inc. 1.40 2000
    9.28% $HK Halcon Resources C 0.41 18160
    9.12% $APDN Applied DNA Scienc 3.95 18420
    9.09% $MPET Magellan Petroleum ...
  • jetace: Unlikely Momentum Stocks: check some old scans and these turned up $IIIN, $OHRP, $ADRO, $NCTY, $ZGNX, $CLDN, $TUES, $TROV, $VTL, $PCRX, $KNDI, $ROVI wishing you all a Happy Thanksgiving
  • mradams0621: ...
    $PCRX Pacira Pharmaceut... 55.78 -9.36%
    $PMCS Pmc-sierra Inc. 10.79 -9.02%
    $BRCD Brocade Communica... 9.33 -7.53%
    $CANF Can-fite Biopharm... 3.16 -6.78%
    $EFUT efuture Informati... 10.81 -6.57%
    $SIG Signet Jewelers 132.00 -6.15%
    $TUR ishares ...
  • DrChucky: $PCRX - big miss, down 16% at 67.05 looking for a possible bounce.
  • Jorma: $PCRX - getting whalloped today after FDA rejected its request for expanding use of its post-op pain med. The expansion would represent 10% of expected revenue moving forward, stock currently down 14%. When this settles, may set up for a trade higher.
  • Jorma: $PCRX - 20 point drop, all the way to 200d.
  • woodman: @Jorma $PCRX http://www.firstwordpharma.com/node/1266543?tsid=28&region_id=6#axzz3TFiXFizn
  • darkenedaura: $PCRX this one very volatile the past two sessions... it makes me a little bit nervous that it's down (after opening up at 118) when the rest of market is up... but I guess as long as it's above that breakout level of 112 I'll just let it work and avoid getting chopped up.
  • DrChucky: $PCRX - 118. now that is a strong stock.!another 4.5%
  • darkenedaura: @DrChucky $PCRX me likey as Dan would say :)
  • DrChucky: $PCRX - new all time high at 113 and change.
  • darkenedaura: $PCRX Blue skies!!! Maybe for ONCE in my SMM life, when I announce it, it won't cause the stock to immediately falter in the next session lol
  • ginny: @darkenedaura $PCRX time for a secondary LOL
  • darkenedaura: @ginny $PCRX or failed trial or something. I have an uncanny ability to jinx stocks. What I need to do is see something breaking out, start a short position and then announce blue skies here... I'd probably have made a fortune in the last year
  • ginny: @darkenedaura $PCRX I started a position in $DIS for our grandaughter 3 years ago..Bought in the 45-50 range. Do not look at it or trade it and you can see what it is worth today. Much to be said about buy and hold good companies. Her combined account is up 55%. Mine is breaking even. LOL
  • darkenedaura: @ginny $PCRX $DIS Honestly I have the same experience. I tried out trading options last year and got a very expensive lesson. Everything else that I did "buy and hold" on is up something like 25-30%. Every. Single. One. I think the lesson learned for me is slow and steady still wins the race... options are exciting but the only time they have really worked out for me is when I've purchased calls out 6-12 months (which is essentially buy and hold anyways). Now if I can just get myself to stop looking at options, maybe I'd be a lot richer :)
  • DrChucky: $PCRX - running upwards against the falling tides. up 5% at 106. closed at 100.50 and lod is 102. no position. but this looks pretty strong.
  • moneyHoHo: $PCRX - missed it!
  • DrChucky: @moneyHoHo - $PCRX - I would not be so sure about that @DAN looked at this recently and said he would not be interested unless it went below 90 or above 110. So that sounds more like a breakout level than an i'm done level to me.
  • DrChucky: $PCRX - still showing a strong uptrend. up 4 bucks and testing 104 with support at 100.
  • darkenedaura: @DrChucky $PCRX still long this one, thanks for the update!
  • DrChucky: $PCRX - climbing steeply off an 85 dollar low the last 9 days, 2 with pullbacks. Back on a steep climb today, above 100 and testing 101. "Investor day" Jan 22. Filling in its large gap down from 104 and change.
  • DrChucky: $PCRX - making a move higher. now re-testing 102.
  • DrChucky: $PCRX - released preliminary revenue numbers and showed strong YOY growth although they were slightly higher than street estimates. Very Strong YoY growth. Exparel revenues up 93% YOY. full year revenues at 197M, up 131% YOY. Showing strength in premarket but bid ask is wide and no volume to speak of. formal numbers released in late Feb.
  • DrChucky: $PCRX - at the 200 day 87.73. consolidating.
  • woodman: $PCRX - bottom-fished this at $87. It's making another run at the 50 day today. There's rooom above recent resistance at the 97 and change level if it can get above that.
  • Lrd123: $PCRX Moving UP
  • darkenedaura: $FB $AAPL $UA $ILMN $TMO $BIDU $SWKS $PCRX all working, I'm a cheerleader today :)
  • DrChucky: $PCRX - nice bowl formation on the daily after its big gap down on earnings day. low of about 87. gap up today to 97 and now showing an indecisive green doji at 95.
  • steve71: $ACAD $CLDX $ISIS $PCRX Another day of small biotech outperforming early. On low volume, so it may mean little. The heavies, $CELG et al, lagging.
  • rj7150: $PCRX Is the class action lawsuit priced into the price here? It appears to be from issues 2 years ago. Looking back in old posts, I don't see it mentioned.
  • dunsek: $PCRX @Aragorn so here's one that has completed the pattern on the daily: 3 red bars, declining volume on each, 3rd is an inside bar and the next bar (yesterday) took out the high from the inside bar. To me, it looks like a low probability trade though, because - we have the 20 and the 100 both above the stock at 94-ish (stock is at 90.74) and both are declining; - the moving average the pattern completed closest to, the 200 day, isn't rising, it's quite flat; - the 3 red bars didn't come as a pause in an uptrend, but as part of some general meandering sideways-to-down Would that be your assessment too, or is there something in this stock's pattern that might catch your eye? Thanks, professor!
  • Aragorn: @dunsek $PCRX yes not a trending stock like a BF and a PB but support at the 8ema. But it looks like the tide is turning as it is moving above the 8ema. It didn't PB to an 8em or a 21ema
  • steve71: $CLDX $ISIS $PCRX $ACAD Small biotech doing well. Curious. I wonder if this is where underperforming funds are looking for a year end push? Low market caps, and easy to push the price around.
  • woodman: $PCRX basing at the 200 day, with 8 dEMA flattening/perhaps curling up a tad. The longer it holds here, the more I am confident it is done going down. I got long a week ago.
  • woodman: $PCRX - this long-time darling's uptrend is clearly broken, but is offering a low risk entry at the 200 day, if at all interested.
  • steve71: $PCRX Reopening a position as the stock bounces off the 200 dma. Chart looks crummy, so using a stop. Buying for fundamentals, not chartology. The product is fantastic for prevention/delay of post-op pain. That means fewer hospital days and less post-op opioids. The company claims less than 1% penetration of their potential market so far. Caveat - recent drop from 110 to 86 because earnings fell short.
  • darkenedaura: $PCRX anyone have thoughts on this one? got seriously wacked on its earnings report... looking very weak here, if any have conviction to stay long please provide it bc i'm getting an itchy trigger finger to bail!
  • Jorma: @darkenedaura $PCRX - the 50dma is 89, I would see if that holds, as it has since at least before March of this year. If that fails, next level is 200 d at 85. This is purely on basis of charts, not earnings, etc.
  • DrChucky: $PCRX - rolling over? bearish engulfing candle so far today. 89.89.
  • DrChucky: $PCRX - bottom right now is 89.75 moving upwards after yesterdays big selloff. earnings beat, gave no guidance, have no sense of why such a big selloff. may be worth a trade as it returns up a bit.
  • darkenedaura: @DrChucky $PCRX ugh yeah I don't understand why it took such a beating :( Gave back a bunch of profits for me, but stops wouldn't have protected me either. I guess I could have sold half before earnings, maybe that's a lesson for next time when I have big profits. Still I bought in the low 70s so I guess I'm just holding for now with a stop below the earnings day. Thinking about adding though...
  • DrChucky: $PCRX - crushed down after earnings. -15% to 89 and.75 may be good for a bounce. headlines said the numbers were good. but ... market says me no like... really no like.
  • DrChucky: @DrChucky - $PCRX - bounced at 89 and change, up to 92 now looking for a second leg down. revenues up 132% YOY. stock down 14%. earnings madness.
  • DrChucky: @tejas7 - missed moves. We have just seen a 10% move up in many many tickers. $ICPT, $PCRX, $GBX, $AKS, $SUNE. too many to list. Hard NOT to feel badly at missing all of that. Feel safe in cash and therefore unstressed about losses, but wondering how well I will do in the upcoming choppy waters. As Dan says, its a dance between the fear of losing positions and the fear of not missing out. Hard not to want to chase now. but I expect the fear to return, and all those buying in big now will be the first to feel it. Buyers at the bottom will be the first to exit, right? So that creates an awful lot of potential sellers with quick trigger fingers. Just thinking out loud - but its thinking that says there is more fear ahead.
  • DrChucky: $PCRX - strong again. missed this move from 94 to 107 and change. oh crap! that's tradin. watching for a pullback now.
  • darkenedaura: @DrChucky $PCRX have to say i love this stock, it's one of the few I can just forget about (a la Dan and Celgene) I just hold it in the long term account and look every once in a blue moon and it's doing well :)
  • DrChucky: @darkenedaura - $PCRX thanks for the thinking. It stopped me out after it hit up near 110. Never did get back in. Not for me at this price.
  • steve71: $ACAD $BIIB $ISIS $PCRX $REGN Biotechs standing firm in the teeth of the storm!
  • DrChucky: $PCRX - continuing to show strength. yesterday as well. off its recent low of 91. now at 97.
  • DrChucky: $PCRX - stronger and stronger. looks like I missed my entry.
  • Jorma: @DrChucky $PCRX - I was looking for it to close above 50d ma before re-entering.
  • DrChucky: $PCRX - back challenging 100 off the low of 93.73. still long.
  • DrChucky: $PCRX - off the low of 92.74. testing 97. long stop at 92. now testing 98. stops raised. now above 99. stops raised.
  • steve71: $PCRX Wonder if the Orthopod used Pacira's Exparel on Dan? Long acting pain relief after surgery is a perfect indication for the drug. Should be great for hips, knees and shoulders, among many other procedures.
  • DrChucky: $PCRX - on sale in pre market. rcvd an FDA warning letter about its marketing claims. dropped from 106 to 98 and change, now at 100. Steady uptrend on this biotech ticker. likely to recover IMHO>
  • DrChucky: $PCRX - squeezing a bit between 100 and 105. testing the top of that range at 104.91. Looking to break out.
  • DrChucky: $PCRX - nice three day move off the low under 100 up to 107, but decreasing volume each day. major resistance at 110, above that blue sky.
  • steve71: $PCRX moving up after establishing a higher low.
  • woodman: @steve71 $PCRX - Watched it bounce off the bottom BB on Friday, but didn't act. I bought some this morning.
  • DrChucky: $PCRX - anybody got a sense of a price target on this one? working well, now above 103. Would adding here be a good idea?
  • Jorma: @DrChucky $PCRX - if you believe in symmetry, on the weekly chart, from the end of March to the beginning of July, the stock had essentially an uninterupted run up from about 65 to 95, or 30 bucks. It pulled back down to 85, and has started back, so a symmetrical move would suggest a 115 target. I sold my stock at 99.50 because I still had Feb '15 80 calls. Although this stock has been outperforming the market, all good things come to an end, and this market is feeling tired, or maybe I am just feeling tired, but FWIW, my target is 115, Dr. Chucky.
  • DrChucky: @Jorma - $PCRX thanks for the input. trade on!
  • Tricia: $PCRX @DrChucky @Jorma .. I guess I use tighter stops than Dr. JOrman .. got bounced out in Marc and again in early July ... Was shopping July 18th and started with it again .. in a month up 25 % .. I decided to cut 1/2 and book profits ...
  • Jorma: $EMES $PCRX $SPY - Lightening up with bombs in Iraq, sold 2/3 of my $EMES stock @ 144.50, sold all of my $PCRX stock @ 99.50 (still long Feb '15 80 calls), for nice gains. BTO $SPY Aug 22 191 puts @2.29, latter for protection, unfortunately already red.
  • DrChucky: $PCRX - testing 100. now testing 101.
  • DrChucky: $PCRX - @DAN covered it recently and its having another decent day. testing 98.00
  • Neil375: $PCRX - Pacira Pharmaceuticals Inc. has hit a new high and pulled back. Looking to get in but it's Friday. Thank you rholden for posting about this one.
  • rholden: Dr Bob $PCRX

    As a SMM member that doesn't correspond and reads daily,I would like to call the forum's attention to PCRX. This company currently is a single drug company without competition for its product. Exparel is an emulsification of a well kn ...
  • Forexpro: @rholden, $PCRX Thanks, Rholden, I know next to nothing - actually, I'm being overly generous to myself - about this sector, but a ticker that breaks a previous high, assuming that occurs, is impressive, particularly on what has been a challening day: http://tos.mx/yLJPJt It looks buyable to me all the way down to 80, with a stop below 77.50 or so. Thanks for the heads up. Best of luck with it.
  • judysteiner: $PCRX-THANKS FOR THAT DR.BOB
Visit the Trading Forum to join in the discussion.
Stock Price $29.04
Change 1.86%
Volume 556,686

Pacira Pharmaceuticals Inc an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products for use in hospitals and ambulatory surgery centers.

Request Video of PCRX
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!